Keralink International, Inc. v. Geri-Care Pharmaceuticals Corporation
| STRADIS HEALTHCARE, LLC, INSOURCE, INC. and KAREWAY PRODUCT, INC. |
| KERALINK INTERNATIONAL, INC. |
| GERI-CARE PHARMACEUTICALS CORPORATION |
| 21-2357 |
| December 7, 2021 |
| U.S. Court of Appeals, Fourth Circuit |
| Other |
Opinions
We have the following opinions for this case:
| Description |
|---|
|
|
Docket Report
This docket was last retrieved on January 10, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 14 APPEARANCE OF COUNSEL by Jonathan A. Barnes for Stradis Healthcare, LLC in 21-2404. [1001089377] [21-2404, 21-2357] Jonathan Barnes [Entered: 01/10/2022 02:46 PM] |
| Filing 13 BRIEFING ORDER filed. Paper copy requirements are temporarily suspended unless the case is under pre-argument review or being scheduled for argument, in which case a total of four paper copies of formal briefs and appendices are required. [1001085868] Opening Brief and Appendix due 02/14/2022. Response Brief due 03/16/2022. [21-2357, 21-2404] KH [Entered: 01/04/2022 05:07 PM] |
Filing 12
ORDER filed consolidating case 21-2404 with 21-2357. Copies to all parties. [1001085856] [21-2357, 21-2404] KH [Entered: 01/04/2022 05:00 PM]
|
Filing 11
ORDER filed rescinding briefing schedule. Copies to all parties. [1001085851] [21-2357] KH [Entered: 01/04/2022 04:56 PM]
|
| Filing 10 Initial mediation conference scheduled. [1001080263] [21-2357] MRB [Entered: 12/23/2021 12:01 PM] |
| Filing 9 DOCKETING STATEMENT by Geri-Care Pharmaceuticals Corporation.. [1001078625] [21-2357] John Perry [Entered: 12/21/2021 10:25 AM] |
Filing 8
APPEARANCE OF COUNSEL by B. Summer Hughes Niazy for Keralink International, Inc.. [1001071781] [21-2357] Bridgette Hughes Niazy [Entered: 12/08/2021 02:54 PM]
|
Filing 7
DISCLOSURE STATEMENT by Keralink International, Inc.. Was any question on Disclosure Form answered yes? No [1001071738] [21-2357] John Bourgeois [Entered: 12/08/2021 01:29 PM]
|
Filing 6
APPEARANCE OF COUNSEL by John A. Bourgeois for Keralink International, Inc.. [1001071663] [21-2357] John Bourgeois [Entered: 12/08/2021 12:08 PM]
|
Filing 5
DISCLOSURE STATEMENT by Geri-Care Pharmaceuticals Corporation. Was any question on Disclosure Form answered yes? Yes [1001071327] [21-2357] John Perry [Entered: 12/07/2021 05:14 PM]
|
Filing 4
APPEARANCE OF COUNSEL by John David Perry for Geri-Care Pharmaceuticals Corporation. [1001071048] [21-2357] John Perry [Entered: 12/07/2021 01:28 PM]
|
Filing 3
BRIEFING ORDER filed. Paper copy requirements are temporarily suspended unless the case is under pre-argument review or being scheduled for argument, in which case a total of four paper copies of formal briefs and appendices are required. [1001071035] Opening Brief and Appendix due 01/18/2022. Response Brief due 02/15/2022. [21-2357] KH [Entered: 12/07/2021 01:17 PM]
|
Filing 2
DOCKETING NOTICE issued Re: [ # 1 ] case. Originating case number: 1:18-cv-02013-CCB. [21-2357] KH [Entered: 12/07/2021 01:09 PM]
|
Filing 1
Case docketed. Originating case number: 1:18-cv-02013-CCB. Case manager: KHancock. [1001071024] [21-2357] KH [Entered: 12/07/2021 01:03 PM]
|
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.